000			01705 a2200505 4500
005			20250514032303.0
264		0	_c20020926
008			200209s 0 0 eng d
022			_a0114-5916
024	7		_a10.2165/00002018-200225040-00005 _2doi
040			_aNLM _beng _cNLM
100	1		_aClaessens, Angela A M C
245	0	0	_aDeterminants of headache in lansoprazole users in The Netherlands: results from a nested case-control study. _h[electronic resource]
260			_bDrug safety _c2002
300			_a287-95 p. _bdigital
500			_aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a2-Pyridinylmethylsulfinylbenzimidazoles
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aCase-Control Studies
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Interactions
650	0	4	_aEnzyme Inhibitors _xadverse effects
650	0	4	_aHeadache _xchemically induced
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aInfant
650	0	4	_aLansoprazole
650	0	4	_aMatched-Pair Analysis
650	0	4	_aMiddle Aged
650	0	4	_aNetherlands
650	0	4	_aOmeprazole _xadverse effects
650	0	4	_aRisk Factors
650	0	4	_aSurveys and Questionnaires
700	1		_aHeerdink, Eibert R
700	1		_avan Eijk, Jacques T H M
700	1		_aLamers, Cornelis B H W
700	1		_aLeufkens, Hubert G M
773	0		_tDrug safety _gvol. 25 _gno. 4 _gp. 287-95
856	4	0	_uhttps://doi.org/10.2165/00002018-200225040-00005 _zAvailable from publisher's website
999			_c11893392 _d11893392